Skip to main content
Caplight Logo









Amped PCR

Amped PCR

Private
AberystwythHealthcare & Life Scienceshttps://www.ampedpcr.co.uk/

Last Round

Grant

May 9, 2025

Total Funding Raised

$1.58M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Amped PCR is a biotechnology company that manufactures high-performance PCR reagents and develops PurifAI, an automated, deployable laboratory system for rapid pathogen detection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Environmental Monitoring, Business Intelligence

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

qPCR reagentspathogen detectionmolecular diagnosticspoint-of-care testingPOCTambient-stable reagentsfood safety testingveterinary diagnosticsenvironmental monitoringOEM manufacturingwhite-label reagentslab-on-a-chipmicrobial intelligenceAI diagnosticsdecentralized testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amped PCR Comparables

Compare Amped PCR with similar companies based on industry and business-model similarity.

Amped PCR comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alveo Technologies
78%
LuminUltra
74%
GeneReach Biotechnology Corp.
73%

Amped PCR Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 9, 2025
SeedDec 16, 2024
GrantOct 1, 2024
Pre SeedApr 5, 2024
GrantOct 2, 2023
Accelerator
Jul 6, 2022

Amped PCR Investors

Notable investors and investment history

Amped PCR investors
InvestorRounds
SFC CapitalSeed, Pre Seed
Welsh GovernmentGrant
Development Bank of WalesSeed, Pre Seed
Ministry of Housing, Communities and Local GovernmentAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 2138% MoM, from 37 to 828.

  • Dec 3, 2025

    Added Scan.com Corporation, a healthcare technology SMB, as a customer.

Amped PCR Filings

Explore SEC and related filing metadata, where available.

Amped PCR filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Amped PCR's valuation, stock price, and market status.

Is Amped PCR a public or private company?

Amped PCR is a private company.

What is the current stock price of Amped PCR?

Amped PCR is a private company with no public stock price. No recent secondary market data is available.

How much is Amped PCR worth (valuation)?

Valuation information for Amped PCR is not publicly available.

Can I buy Amped PCR stock?

Amped PCR shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Amped PCR's last funding round?

Amped PCR's most recent funding round was Grant on May 9, 2025.

Who are the main investors in Amped PCR?

Key investors in Amped PCR include SFC Capital, Welsh Government, Development Bank of Wales, Ministry of Housing, Communities and Local Government.

Will Amped PCR IPO soon?

No public IPO plans have been announced for Amped PCR.

How can I track Amped PCR secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amped PCR's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAberystwyth
Employee Range1
Year Founded2020
Last FundingMay 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?